"整形外科、リハビリテーション科、内科、循環器内科、神経内科、脳神経外科、外科、リウマチ科、麻酔科を掲げ、地域の皆さまに愛され期待される病院を目指します。紹介状がなくても受診できます。健康がすぐれない時は、どうぞ遠慮なくご相談ください。"

During the past decade, Souseikai Fukuoka Mirai Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 6 clinical trials were completed, i.e. on average, 31.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Souseikai Fukuoka Mirai Hospital" #1 sponsor was "Bayer" with 5 trials, followed by "Janssen Pharmaceutical K.K." with 5 trials sponsored, "Pfizer" with 3 trials sponsored, "Takeda" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Souseikai Fukuoka Mirai Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Janssen Research & Development, LLC" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Souseikai Fukuoka Mirai Hospital" are "Healthy" (5 trials), "Healthy Volunteers" (3 trials), "Clinical Pharmacology" (2 trials), "Low Back Pain" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Souseikai Fukuoka Mirai Hospital" in a lesser frequency.

Most popular intervention types in "Souseikai Fukuoka Mirai Hospital" are "Drug" (16 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Rivaroxaban (BAY 59-7939, Xarelto) in ODT form" (2 trials), "Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form" (2 trials), "Ad26.COV2.S" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Souseikai Fukuoka Mirai Hospital" are 9 trials for "All" genders, 9 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Souseikai Fukuoka Mirai Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Souseikai Fukuoka Mirai Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Souseikai Fukuoka Mirai Hospital, 14 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".